These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 4740783)
1. [Treatment of hematopoietic proliferative syndromes with a semi-synthetic podophyllin derivative]. Lawkowicz W; Krzemińska-Lawkowiczowa ; Polubiec A; Kolakowska-Polubiec K; Domańska B; Kolakowski L Acta Haematol Pol; 1973; 4(2):123-7. PubMed ID: 4740783 [No Abstract] [Full Text] [Related]
2. [Effectiveness of polychemotherapeutic treatments of lymphoproliferative diseases]. Cajozzo A; Citarrella P; Carreca I; D'Eredità F Haematologica; 1970; 55(7):465-70. PubMed ID: 4996520 [No Abstract] [Full Text] [Related]
3. [Results obtained with the clinical use of adriamycin]. Esposito S; Taylor LA Haematologica; 1971; 56(9):343-66. PubMed ID: 5004536 [No Abstract] [Full Text] [Related]
4. [Results of cytostatic therapy of malignant hemoblastoses]. Stacher A Wien Z Inn Med; 1966 Jan; 47(1):1-16. PubMed ID: 4962311 [No Abstract] [Full Text] [Related]
5. [Acute leukemia and various hematosarcomas. Trial treatment with a second derivative of podophyllotoxin (4-demethyl-epipodophyllotoxin beta D ethylidene glucoside VP 16213 or EPE)]. Mathé G; Schwarzenberg L; Pouillart P; Weiner R; Oldham R; Jasmin C; Rosenfeld C; Hayat M; Schneider M; Amiel JL; Céoara B; Steresco-Musset M; de Vassal F Nouv Presse Med; 1974 Mar; 3(9):521-4. PubMed ID: 4595555 [No Abstract] [Full Text] [Related]
6. [Personal experience on the chemotherapy of leukemias and hematosarcomas]. Mathé G; Schneider M; Schwarzenberg L; Cattan A; Amiel JL; Schlumberger JR Acta Genet Med Gemellol (Roma); 1968 Jan; 17(1):245-54. PubMed ID: 4874537 [No Abstract] [Full Text] [Related]
7. Leukemia and lymphoma. White LP Geriatrics; 1970 Dec; 25(12):82-6. PubMed ID: 5274229 [No Abstract] [Full Text] [Related]
8. Adrenal steroids in leukemia and lymphoma. Cline MJ Cancer Chemother Rep; 1974; 58(4):521-5. PubMed ID: 4368378 [No Abstract] [Full Text] [Related]
9. Clinical investigation of a new podophyllum derivative, epipodophyllotoxin, 4'-demethyl-9-(4,6-O-2-thenylidene- -D-glucopyranoside) (NSC-122819), in patients with malignant lymphomas and solid tumors. Dombernowsky P; Nissen NI; Larsen V Cancer Chemother Rep; 1972 Feb; 56(1):71-82. PubMed ID: 4624138 [No Abstract] [Full Text] [Related]
10. [Therapy of hemoblastosis. I. Elements of cytostatic and symptomatic therapy]. Danieli G G Clin Med; 1966 Aug; 47(8):732-68. PubMed ID: 4865460 [No Abstract] [Full Text] [Related]
11. Two epipodophyllotoxin derivatives, VM 26 and VP 16213, in the treatment of leukemias, hematosarcomas, and lymphomas. Mathé G; Schwarzenberg L; Pouillart P; Oldham R; Weiner R; Jasmin C; Rosenfeld C; Hayat M; Misset JL; Musset M; Schneider M; Amiel JL; De Vassal F Cancer; 1974 Oct; 34(4):985-92. PubMed ID: 4608026 [No Abstract] [Full Text] [Related]
12. Clinical screening of epipodophyllotoxin VM26 in malignant lymphomas and solid tumours. Br Med J; 1972 Jun; 2(5816):744-8. PubMed ID: 4556544 [TBL] [Abstract][Full Text] [Related]
13. [Clinical research on the antipyretic effects of indomethacin in systemic hemopathies]. Marcolongo R; Bianco G; Di Paolo N; Bravi A Minerva Med; 1970 Oct; 61(82):4532-41. PubMed ID: 5273365 [No Abstract] [Full Text] [Related]
14. Study of Leo-1031 (NSC-134087) in lymphocytic lymphoma and chronic lymphocytic leukemia. Kaufman JH; Hanjura GL; Mittelman A; Aungst CW; Murphy GP Cancer Treat Rep; 1976 Mar; 60(3):277-9. PubMed ID: 946596 [No Abstract] [Full Text] [Related]
16. [Methylhydrazine in the therapy of malignant lymphopathies]. Beltrametti L; Almici C Policlinico Prat; 1967 Jan; 74(3):82-5. PubMed ID: 4878309 [No Abstract] [Full Text] [Related]
17. [4-year-observation of results of VM 26 treatment of pathologic syndromes from the lymphoma malignum group]. Lawkowicz W; Polubiec A; Domańska B Acta Haematol Pol; 1975; 6(2):143-7. PubMed ID: 1098351 [TBL] [Abstract][Full Text] [Related]